323 related articles for article (PubMed ID: 22157640)
1. Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
Quinten C; Maringwa J; Gotay CC; Martinelli F; Coens C; Reeve BB; Flechtner H; Greimel E; King M; Osoba D; Cleeland C; Ringash J; Schmucker-Von Koch J; Taphoorn MJ; Weis J; Bottomley A
J Natl Cancer Inst; 2011 Dec; 103(24):1851-8. PubMed ID: 22157640
[TBL] [Abstract][Full Text] [Related]
2. Adverse symptom event reporting by patients vs clinicians: relationships with clinical outcomes.
Basch E; Jia X; Heller G; Barz A; Sit L; Fruscione M; Appawu M; Iasonos A; Atkinson T; Goldfarb S; Culkin A; Kris MG; Schrag D
J Natl Cancer Inst; 2009 Dec; 101(23):1624-32. PubMed ID: 19920223
[TBL] [Abstract][Full Text] [Related]
3. The Added Value of Analyzing Pooled Health-Related Quality of Life Data: A Review of the EORTC PROBE Initiative.
Zikos E; Coens C; Quinten C; Ediebah DE; Martinelli F; Ghislain I; King MT; Gotay C; Ringash J; Velikova G; Reeve BB; Greimel E; Cleeland CS; Flechtner H; Taphoorn MJ; Weis J; Schmucker-von Koch J; Sprangers MA; Bottomley A;
J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26714759
[TBL] [Abstract][Full Text] [Related]
4. Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.
Reeve BB; Mitchell SA; Dueck AC; Basch E; Cella D; Reilly CM; Minasian LM; Denicoff AM; O'Mara AM; Fisch MJ; Chauhan C; Aaronson NK; Coens C; Bruner DW
J Natl Cancer Inst; 2014 Jul; 106(7):. PubMed ID: 25006191
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.
Lim AW; Mesher D; Gentry-Maharaj A; Balogun N; Jacobs I; Menon U; Sasieni P
J Natl Cancer Inst; 2012 Jan; 104(2):114-24. PubMed ID: 22247022
[TBL] [Abstract][Full Text] [Related]
6. Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials.
Quinten C; Coens C; Mauer M; Comte S; Sprangers MA; Cleeland C; Osoba D; Bjordal K; Bottomley A;
Lancet Oncol; 2009 Sep; 10(9):865-71. PubMed ID: 19695956
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and quality of life outcomes in ovarian cancer patients participating in randomized controlled trials.
Greimel ER; Bjelic-Radisic V; Pfisterer J; Hilpert F; Daghofer F; Pujade-Lauraine E; du Bois A; ;
Support Care Cancer; 2011 Sep; 19(9):1421-7. PubMed ID: 20694564
[TBL] [Abstract][Full Text] [Related]
8. A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
Quinten C; Martinelli F; Coens C; Sprangers MA; Ringash J; Gotay C; Bjordal K; Greimel E; Reeve BB; Maringwa J; Ediebah DE; Zikos E; King MT; Osoba D; Taphoorn MJ; Flechtner H; Schmucker-Von Koch J; Weis J; Bottomley A;
Cancer; 2014 Jan; 120(2):302-11. PubMed ID: 24127333
[TBL] [Abstract][Full Text] [Related]
9. The impact of radiotherapy on quality of life for cancer patients: a longitudinal study.
Yucel B; Akkaş EA; Okur Y; Eren AA; Eren MF; Karapinar H; Babacan NA; Kiliçkap S
Support Care Cancer; 2014 Sep; 22(9):2479-87. PubMed ID: 24728584
[TBL] [Abstract][Full Text] [Related]
10. Validity and Reliability of the US National Cancer Institute's Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Dueck AC; Mendoza TR; Mitchell SA; Reeve BB; Castro KM; Rogak LJ; Atkinson TM; Bennett AV; Denicoff AM; O'Mara AM; Li Y; Clauser SB; Bryant DM; Bearden JD; Gillis TA; Harness JK; Siegel RD; Paul DB; Cleeland CS; Schrag D; Sloan JA; Abernethy AP; Bruner DW; Minasian LM; Basch E;
JAMA Oncol; 2015 Nov; 1(8):1051-9. PubMed ID: 26270597
[TBL] [Abstract][Full Text] [Related]
11. Comparison of EORTC QLQ-C30 and PRO-CTCAE™ Questionnaires on Six Symptom Items.
Taarnhøj GA; Kennedy FR; Absolom KL; Bæksted C; Vogelius IR; Johansen C; Velikova G; Pappot H
J Pain Symptom Manage; 2018 Sep; 56(3):421-429. PubMed ID: 29807157
[TBL] [Abstract][Full Text] [Related]
12. The relationship between global and specific components of quality of life, assessed with the EORTC QLQ-C30 in a sample of 2019 cancer patients.
Hinz A; Mehnert A; Dégi C; Reissmann DR; Schotte D; Schulte T
Eur J Cancer Care (Engl); 2017 Mar; 26(2):. PubMed ID: 26568527
[TBL] [Abstract][Full Text] [Related]
13. Quality of life as a prognostic indicator of survival: A pooled analysis of individual patient data from canadian cancer trials group clinical trials.
Ediebah DE; Quinten C; Coens C; Ringash J; Dancey J; Zikos E; Gotay C; Brundage M; Tu D; Flechtner HH; Greimel E; Reeve BB; Taphoorn M; Reijneveld J; Dirven L; Bottomley A;
Cancer; 2018 Aug; 124(16):3409-3416. PubMed ID: 29905936
[TBL] [Abstract][Full Text] [Related]
14. Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study.
Basch E; Iasonos A; McDonough T; Barz A; Culkin A; Kris MG; Scher HI; Schrag D
Lancet Oncol; 2006 Nov; 7(11):903-9. PubMed ID: 17081915
[TBL] [Abstract][Full Text] [Related]
15. Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
Coomans MB; Dirven L; Aaronson NK; Baumert BG; Van Den Bent M; Bottomley A; Brandes AA; Chinot O; Coens C; Gorlia T; Herrlinger U; Keime-Guibert F; Malmström A; Martinelli F; Stupp R; Talacchi A; Weller M; Wick W; Reijneveld JC; Taphoorn MJB
Neuro Oncol; 2019 Nov; 21(11):1447-1457. PubMed ID: 31682733
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
Falchook AD; Green R; Knowles ME; Amdur RJ; Mendenhall W; Hayes DN; Grilley-Olson JE; Weiss J; Reeve BB; Mitchell SA; Basch EM; Chera BS
JAMA Otolaryngol Head Neck Surg; 2016 Jun; 142(6):517-23. PubMed ID: 27149571
[TBL] [Abstract][Full Text] [Related]
17. Health care providers underestimate symptom intensities of cancer patients: a multicenter European study.
Laugsand EA; Sprangers MA; Bjordal K; Skorpen F; Kaasa S; Klepstad P
Health Qual Life Outcomes; 2010 Sep; 8():104. PubMed ID: 20858248
[TBL] [Abstract][Full Text] [Related]
18. Test/retest study of the European Organization for Research and Treatment of Cancer Core Quality-of-Life Questionnaire.
Hjermstad MJ; Fossa SD; Bjordal K; Kaasa S
J Clin Oncol; 1995 May; 13(5):1249-54. PubMed ID: 7738629
[TBL] [Abstract][Full Text] [Related]
19. Determinants of overall quality of life in preterminal cancer patients.
Beijer S; Kempen GI; Pijls-Johannesma MC; de Graeff A; Dagnelie PC
Int J Cancer; 2008 Jul; 123(1):232-5. PubMed ID: 18412247
[TBL] [Abstract][Full Text] [Related]
20. How best to assess the quality of life in long-term survivors after surgery for NSCLC? Comparison between clinical predictors and questionnaire scores.
Sterzi S; Cesario A; Cusumano G; Corbo G; Lococo F; Biasotti B; Lapenna LM; Magrone G; Dall'armi V; Meacci E; Porziella V; Bonassi S; Margaritora S; Granone P
Clin Lung Cancer; 2013 Jan; 14(1):78-87. PubMed ID: 22607778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
